The Cochrane Collaboration
- Company typePrivate
- Founded1992
- HeadquartersLondon, United Kingdom
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingServices
The Cochrane Collaboration firmographics
Firmographics- Name
- The Cochrane Collaboration
- Legal name
- The Cochrane Collaboration
- Website
- https://cochrane.org
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
The Cochrane Collaboration industry classification
Industry- Product category
- Health Evidence Synthesis
- NAICS
- Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)
- akta.pro secondary industry
- Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)
Keywords
Where The Cochrane Collaboration is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
The Cochrane Collaboration business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Others
Revenue model
- Charitable Grants and Donations: As a registered charity (no. 1045921) in England & Wales, Cochrane is primarily funded through grants, donations, and institutional funding partnerships. The organization operates as a company limited by guarantee (no. 03044323).
- Publishing and Licensing: Cochrane Library content is published through Wiley, with some resources available open access and others behind subscription access for institutions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free access to evidence summaries and plain language summaries |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
The Cochrane Collaboration product offering
Product offeringCore offering
The Cochrane Collaboration produces high-quality systematic reviews of healthcare interventions and publishes them through the Cochrane Library, supported by its proprietary Review Manager (RevMan) authoring software, the CENTRAL database of controlled trials, and method-handbooks such as the Cochrane Handbook for Systematic Reviews of Interventions. The organization also offers Cochrane Crowd, Screen4Me, the open-access Cochrane Evidence Synthesis and Methods journal, and the RAISE framework for responsible AI use, serving clinicians, researchers, policymakers, patients, and the public across 100+ countries.
Product overview
The Cochrane Collaboration is a global network that produces trusted health evidence through systematic reviews. Its primary product is the Cochrane Library (containing the Cochrane Database of Systematic Reviews and CENTRAL), supported by the Cochrane Handbook for Systematic Reviews of Interventions and Review Manager (RevMan) software. Cochrane offers complementary tools including Cochrane Crowd and Screen4Me for study identification, and recommends third-party tools like Covidence and EPPI-Reviewer for review production. The organization also provides specialized products including the Cochrane Evidence Synthesis and Methods open access journal and the Cochrane Rehabilitation thematic group. Cochrane is actively exploring AI tools for evidence synthesis through initiatives like the CESAR platform study, guided by the RAISE framework for responsible AI use.
Differentiator
Problem solved
Functional benefit
Brands
- Cochrane Library: The primary platform for Cochrane's systematic reviews and evidence synthesis content
- Cochrane Rehabilitation
- Cochrane Evidence Synthesis and Methods
Products and services
- Cochrane Library An online collection of databases containing high-quality independent evidence to inform healthcare decision-making, including the Cochrane Database of Systematic Reviews (CDSR) and the Cochrane Central Register of Controlled Trials (CENTRAL). It is the primary platform for accessing Cochrane's systematic reviews, available through both open access content and institutional subscriptions.
- Review Manager (RevMan) Cochrane's proprietary, mandatory, free-to-use software for preparing Cochrane reviews, providing structured text drafting, standard tables, reference formats, meta-analysis capabilities, online help, and error checking, used for editorial submission and publication.
- Cochrane Handbook for Systematic Reviews of Interventions The official Cochrane Handbook providing comprehensive methodological guidance on conducting systematic reviews of interventions, covering all aspects from planning a review through to completion and updating; current version 6.5.
- Cochrane Central Register of Controlled Trials (CENTRAL) A highly concentrated source of reports of randomized and quasi-randomized controlled trials, populated using centralized searches, machine learning technology, and Cochrane Crowd screening, used to populate Cochrane systematic reviews.
- Cochrane Crowd A crowd-based system that enables volunteers to screen search results to identify randomized trials and other study types, supporting the identification of relevant studies for inclusion in Cochrane reviews.
- Screen4Me A service available to Cochrane review authors that uses machine learning to screen and identify relevant studies for inclusion, particularly for reviews with complex searches and large record sets.
- Cochrane Evidence Synthesis and Methods A fully open access journal that aims to develop the evidence base for how Cochrane produces and publishes evidence syntheses, accepting methods research, scoping reviews, rapid reviews, and evidence gap maps.
- Cochrane Rehabilitation, Functioning, and Disability A Cochrane Thematic Group focused on advancing research, refining clinical practices, and enhancing functioning outcomes and quality of life for people with disabling health conditions, supporting evidence production, implementation, and evidence-based practices in rehabilitation worldwide.
- RAISE (Responsible use of AI in evidence SynthEsis) Guidance Cochrane guidance on the responsible use of AI in evidence synthesis, providing recommendations and a responsible handover framework for selecting and using AI tools in systematic reviews.
Quantifiable outcome
- Two thirds of new WHO guidelines cite at least 1 Cochrane review in the past 5 years
- +1 more outcomes
Companies that use The Cochrane Collaboration
Customer profileSegments4 records
Ideal customer profiles4 records
The Cochrane Collaboration technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability4 records
Feature5 records
The Cochrane Collaboration partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered flagship, core and minor.
- World Health Organization (WHO)flagshipCochrane holds official relations status with WHO, providing a stronger platform at the World Health Assembly to advocate for and contribute evidence. Cochrane's CEO participates in WHO events, and WHO guidelines frequently cite Cochrane reviews. This relationship reinforces Cochrane's role in evidence-to-policy systems.
- JBI (Joanna Briggs Institute)coreJBI is a founding partner of World Evidence-based Healthcare Day alongside Cochrane, The Campbell Collaboration, Institute of Development Studies, Centre for Evidence-based Health Care, and Instituto Veredas.
- The Campbell CollaborationcoreCo-founder of World Evidence-based Healthcare Day, partnering with Cochrane and other organizations dedicated to evidence-informed decision-making.
- DevexminorCochrane partnered with Devex to host a high-level reception at the World Health Assembly, bringing together global health leaders and funders.
- WileycoreCochrane Library content is published through Wiley. International journals publish Cochrane Corners according to agreements between Cochrane Rehabilitation and Wiley.
- GIN (Guidelines International Network)minorSupporting partner of World Evidence-based Healthcare Day 2026 campaign.
- HTiA (Health Technology Assessment International)minorSupporting partner of World Evidence-based Healthcare Day 2026 campaign.
- The Africa Evidence Youth LeagueminorSupporting partner of World Evidence-based Healthcare Day 2026 campaign focused on youth engagement in evidence-based healthcare.
- Cochrane Rehabilitation Partner National SocietiescoreNetwork of national societies (Association of Academic Physiatrists, Belgian, Catalan, Finnish, French, German, Hellenic, Hungarian, Indonesian, Italian, Netherlands, Romanian, Slovenian, Turkish societies of Physical Medicine and Rehabilitation) involved in education activities, translation, and dissemination of Cochrane content.
Scale indicators6 records
Recent moves6 records
Expansion highlights7 records
The Cochrane Collaboration competitors and assessment
Company assessmentDirect peers
- Joanna Briggs Institute (JBI): JBI is the most direct peer to Cochrane — an international evidence-based healthcare research organization producing systematic reviews and implementation resources. JBI is a co-founding partner of World Evidence-based Healthcare Day alongside Cochrane, serves similar clinician/policymaker audiences, and competes in the same evidence-synthesis methodology space.
- Campbell Collaboration: Campbell Collaboration produces systematic reviews of social and economic interventions, mirroring Cochrane's role in health. As a co-founding partner of World Evidence-based Healthcare Day, Campbell competes for the same funder pool and applies overlapping methodological standards, making it a direct peer in the systematic-review infrastructure space.
- Epistemonikos: Epistemonikos is a collaborative, multilingual database of systematic reviews relevant for health decision-making — directly comparable to Cochrane Library as an evidence-aggregation platform. It aggregates reviews from multiple sources (including Cochrane) and serves the same clinician and policymaker audience, making it a direct peer in evidence aggregation.
- PROSPERO (University of York): PROSPERO is the international prospective register of systematic reviews hosted by the University of York's Centre for Reviews and Dissemination. It is directly comparable to Cochrane's review-protocol infrastructure and serves overlapping researcher audiences planning systematic reviews in health and social care.
Broad incumbents
- Agency for Healthcare Research and Quality (AHRQ): AHRQ is a US federal agency that funds and produces comparative-effectiveness research and systematic reviews. It is a broad incumbent operating in the same health-evidence space as Cochrane but with a US-government mandate and different funding model, serving overlapping policymaker and clinician audiences.
- National Institute for Health and Care Excellence (NICE): NICE produces health technology assessments and clinical guidelines for the UK NHS, frequently drawing on Cochrane systematic reviews as primary inputs. It is a broad incumbent in evidence-to-policy translation, overlapping with Cochrane on guideline-informing evidence but operating one step downstream in the recommendation pipeline.
Emerging players
- GRADE Working Group: The GRADE Working Group develops the methodology for grading the certainty of evidence and strength of recommendations — used by Cochrane for Summary of Findings tables. It is an emerging/methodological player that defines the standards Cochrane applies, making it a peer at the methodology layer even though it does not produce reviews directly.
Others
- World Health Organization (WHO): WHO is Cochrane's flagship strategic partner and the largest consumer of Cochrane evidence (two-thirds of new guidelines cite Cochrane reviews). It is included here as a peer/ecosystem participant because it also produces evidence syntheses and guidelines, and its strategic priorities directly shape Cochrane's relevance.
- Wellcome Trust: Wellcome Trust is a major funder of Cochrane (e.g., grant 323143/Z/24/Z supporting the CESAR AI project). It is an ecosystem/financial peer — not a direct competitor — but its funding decisions and broader research-integrity priorities materially shape Cochrane's strategic options.
- Wiley: Wiley is Cochrane's publishing partner for the Cochrane Library and Cochrane Evidence Synthesis and Methods journal, and coordinates Cochrane Corners distribution through partner journals. Wiley is an ecosystem/partner peer rather than a competitor, but its commercial decisions materially affect Cochrane's distribution and licensing revenue.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
The Cochrane Collaboration social profiles
Digital presenceThe Cochrane Collaboration financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Cochrane Collaboration leadership team
Management profileNumber of profiles
Profiles6 records
The Cochrane Collaboration funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Cochrane Collaboration M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Cochrane Collaboration
What does The Cochrane Collaboration do?
The Cochrane Collaboration produces high-quality systematic reviews of healthcare interventions and publishes them through the Cochrane Library, supported by its proprietary Review Manager (RevMan) authoring software, the CENTRAL database of controlled trials, and method-handbooks such as the Cochrane Handbook for Systematic Reviews of Interventions. The organization also offers Cochrane Crowd, Screen4Me, the open-access Cochrane Evidence Synthesis and Methods journal, and the RAISE framework for responsible AI use, serving clinicians, researchers, policymakers, patients, and the public across 100+ countries.
Is The Cochrane Collaboration a public or private company?
The Cochrane Collaboration is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Cochrane Collaboration founded?
The Cochrane Collaboration was founded in 1992. It employs 5,001 to 10,000 people.
Where is The Cochrane Collaboration based?
The Cochrane Collaboration is headquartered in London, United Kingdom, in the Europe region.
How does The Cochrane Collaboration make money?
Two revenue lines are on record. Charitable Grants and Donations are the primary driver. The others are publishing and Licensing.
Who are The Cochrane Collaboration's main competitors?
Direct peers on record are Joanna Briggs Institute (JBI), Campbell Collaboration, Epistemonikos and PROSPERO (University of York). Broad incumbents are Agency for Healthcare Research and Quality (AHRQ) and National Institute for Health and Care Excellence (NICE). GRADE Working Group is listed as an emerging player. Others are World Health Organization (WHO), Wellcome Trust and Wiley.
Does The Cochrane Collaboration have an API?
No public API is recorded for The Cochrane Collaboration.
What industry is The Cochrane Collaboration in?
The Cochrane Collaboration's product category is Health Evidence Synthesis. Its primary akta.pro industry code is HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations, with a secondary code of HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms. Its NAICS code is 541690 and its SIC code is 8731.